Skip to content

Episodic-like memory impairment induced by sub-anaesthetic doses of ketamine.

Ingrid Brasilino Montenegro Bento De Souza, Ywlliane da Silva Rodrigues Meurer, Priscila Macedo Tavares, Karen Cristina Pugliane, Ramón Hypolito Lima, Regina Helena Silva, Flávio Freitas Barbosa

Behavioural Brain Research February 1, 2019 DOI: 10.1016/j.bbr.2018.10.031 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Experimental animal study Peer reviewed
Population Wistar rats
Intervention Ketamine
Dose 8 mg/kg or 15 mg/kg (i.p.)
Measures WWWhen/ELM task, c-Fos expression
Topics Ketamine Esketamine
Keywords Episodic-like memory Wistar rats C-fos
Key findings Ketamine at 8 mg/kg or 15 mg/kg given after the second sample impaired formation of episodic-like memory across all three elements (what, where, when), whereas untreated and saline-treated rats integrated them. The 15 mg/kg dose also increased c-Fos expression in the dorsal CA1 subregion relative to saline. The authors interpret this as NMDA receptor antagonism concurrently impairing episodic-like memory formation and increasing neuronal activation in dorsal CA1.

Abstract

Episodic-like memory refers to integration of where and when a certain event (what) happened. The glutamatergic neurotransmission, particularly AMPA and NMDA receptors, in the dorsal hippocampus mediates episodic recall. Ketamine is a non-competitive NMDA antagonist with effect on cognitive performance and plasticity. The goal of this study was to evaluate the acute action of ketamine on behavioural and neurochemical aspects of episodic-like memory (WWWhen/ELM task) through immediate-early gene expression (IEG), c-Fos, in the dorsal hippocampus. Animals received saline 0.9% or ketamine at 8 mg/kg or 15 mg/kg (i.p.) immediately after the second sample. Our data indicate that untreated and saline rats integrate the three elements of episodic-like memory. Conversely, animals treated with ketamine showed impairment of ELM formation. In addition, the highest dose of ketamine increased c-Fos expression in dorsal CA1 subregion when compared to saline rats. Our results indicate that the antagonism of NMDA concurrently impair ELM formation of all three aspects of ELM and increase neuronal activation in dorsal CA1.

Comparable studies

Other preclinical and animal studies on ketamine, most cited first.

Citations in the library

Explore topics